BRILINTA

astrazeneca canada inc🇨🇦 Health Canada

Approval Id: a82c36ab992077e9
Drug Approval Canada Name: BRILINTA
Product Name: BRILINTA
Status: Marketed
Status Date: 2016-06-13
Original Market Date: 2016-06-13
Din: 02455005
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 20:12.18
Atc Original: B01AC24 TICAGRELOR
Atc Name: b 01 ac 24
Aig Number: 0152934002
Company Name: astrazeneca canada inc
Company Address: 1004 Middlegate Road, Suite 5000, Mississauga, Ontario, Canada, L4Y 1M4

TICAGRELOR

60 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

a82c36ab992077e9

Type

Standard